Octreotide Acetate (West-Ward Pharmaceuticals Corp.)
Welcome to the PulseAid listing for the Octreotide Acetate drug offered from West-Ward Pharmaceuticals Corp.. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | West-Ward Pharmaceuticals Corp. |
NON-PROPRIETARY NAME: | Octreotide Acetate |
SUBSTANCE NAME: | OCTREOTIDE ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2005-04-04 |
END MARKETING DATE: | 0000-00-00 |
Octreotide Acetate HUMAN PRESCRIPTION DRUG Details:
Item Description | Octreotide Acetate from West-Ward Pharmaceuticals Corp. |
LABELER NAME: | West-Ward Pharmaceuticals Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(ug/mL) |
START MARKETING DATE: | 2005-04-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0641-6174_61fe5dbc-007f-409d-bc92-3ee11a528678 |
PRODUCT NDC: | 0641-6174 |
APPLICATION NUMBER: | ANDA076313 |
Other OCTREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers: